Journey Medical (DERM) EPS (Weighted Average and Diluted) (2020 - 2026)
Journey Medical (DERM) reported EPS (Weighted Average and Diluted) of -$0.08 for Q1 2026, up 55.56% on a YoY basis from -$0.05 in Q1 2025, and down 100.0% quarter-over-quarter from -$0.04 in Q4 2025.
Journey Medical (DERM) EPS (Weighted Average and Diluted) (2020 - 2026) Analysis & Trends
Journey Medical has reported EPS (Weighted Average and Diluted) for 7 years, with the latest figure at -$0.08 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 55.56% year-over-year to -$0.08; the trailing twelve-month figure through Mar 2026 stood at -$0.37 (up 5.13% YoY), and the FY2025 full-year result was -$0.47, up 34.72% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.08, down from -$0.04 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $0.8 in Q3 2023, with the low at -$0.6 in Q4 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.2 across 5 years, with a median of -$0.16 in 2025.
- The largest YoY upside for EPS (Weighted Average and Diluted) was 240.35% in 2023 against a maximum downside of 612.5% in 2023.
- Journey Medical's EPS (Weighted Average and Diluted) stood at -$0.6 in 2022, then soared by 80.0% to -$0.12 in 2023, then soared by 166.67% to $0.08 in 2024, then slumped by 150.0% to -$0.04 in 2025, then tumbled by 100.0% to -$0.08 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.08 (Q1 2026), -$0.04 (Q4 2025), and -$0.09 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -0.40 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -0.40 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.80 |
| 10 | Journey Medical | 168.75 Mn | 141.53 Mn | 9.70 Mn | -0.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.08 |
| Dec 31, 2025 | -0.04 |
| Sep 30, 2025 | -0.09 |
| Jun 30, 2025 | -0.16 |
| Mar 31, 2025 | -0.18 |
| Dec 31, 2024 | 0.08 |
| Sep 30, 2024 | -0.12 |
| Jun 30, 2024 | -0.17 |
| Mar 31, 2024 | -0.53 |
| Dec 31, 2023 | -0.12 |
| Sep 30, 2023 | 0.80 |
| Jun 30, 2023 | -0.46 |
| Mar 31, 2023 | -0.57 |
| Dec 31, 2022 | -0.60 |
| Sep 30, 2022 | -0.57 |
| Jun 30, 2022 | -0.43 |
| Mar 31, 2022 | -0.08 |
| Dec 31, 2021 | -1.89 |
| Sep 30, 2021 | -1.16 |
| Jun 30, 2021 | -1.30 |